DHG Pharmaceutical Joint Stock Company reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was VND 1,119,267 million compared to VND 947,836.08 million a year ago. Net income was VND 234,569.89 million compared to VND 201,067.48 million a year ago. Basic earnings per share from continuing operations was VND 1,736 compared to VND 1,480 a year ago.
For the six months, revenue was VND 2,184,042.39 million compared to VND 1,965,219.91 million a year ago. Net income was VND 489,870.31 million compared to VND 405,414.78 million a year ago. Basic earnings per share from continuing operations was VND 3,627 compared to VND 2,985 a year ago.